Evidence map›Paper›PMID 41300086›Full record

ArticleFoods (Basel, Switzerland)2025

Profiling Neuroactive Compounds in Organic, Conventional, and Processed Tomatoes.

Ana Kovačič, Mar Garcia-Aloy, Domenico Masuero, Vania Sáez, Anže Brus, Pietro Franceschi, Urška Vrhovšek

Abstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ana KovačičMetabolomics Unit, Research and Innovation Centre, Fondazione Edmund Mach, 38098 San Michele all'Adige, Italy.ORCID 0000-0003-1578-7363
Mar Garcia-AloyMetabolomics Unit, Research and Innovation Centre, Fondazione Edmund Mach, 38098 San Michele all'Adige, Italy.ORCID 0000-0002-1330-6610
Domenico MasueroMetabolomics Unit, Research and Innovation Centre, Fondazione Edmund Mach, 38098 San Michele all'Adige, Italy.ORCID 0000-0003-0696-3206
Vania SáezMetabolomics Unit, Research and Innovation Centre, Fondazione Edmund Mach, 38098 San Michele all'Adige, Italy.
Anže BrusMetabolomics Unit, Research and Innovation Centre, Fondazione Edmund Mach, 38098 San Michele all'Adige, Italy.
Pietro FranceschiDigital Agriculture Unit, Research and Innovation Centre, Fondazione Edmund Mach, 38098 San Michele all'Adige, Italy.ORCID 0000-0001-5711-4429
Urška VrhovšekMetabolomics Unit, Research and Innovation Centre, Fondazione Edmund Mach, 38098 San Michele all'Adige, Italy.

Funding

European Union under Horizon Europe (HORIZON) - MSCA postdoctoral Fellowships 101062798
6 · The paper itself

Abstract

Despite growing evidence linking diet to neurodegenerative diseases, the connection remains unclear. Tomatoes, a widely consumed food, have been proposed as potential sources of neuroactive compounds. Using LC-MS/MS, we profiled organic and conventional "datterini," plump, and processed tomatoes. Six carotenoids were quantified, with phytoene and lycopene being the most abundant. Multivariate analysis revealed that processing and variety, rather than organic vs. conventional methods, drove dataset variability. Seventy neuroactive compounds were identified, some distinguishing tomato variety, processing, and/or production methods. Processed tomatoes generally showed higher abundance of neuroactive compounds than fresh tomatoes, and "datterini" tomatoes contained more neuroprotective compounds than plump tomatoes. Organic "datterini" did not have higher neuroprotective compound levels than conventional ones. These findings suggest thermal processing may alter the compositional quality of tomatoes, potentially enhancing the levels of certain bioactive constituents, while organic cultivation does not inherently increase the abundance of neuroprotective compounds. Overall, tomatoes represent a complex source of both neuroprotective and neuro-disrupting compounds, warranting further research on their bioaccessibility and physiological relevance.

Indexed as

annotationmass spectrometryneuroactive chemical profileneuro-disrupting compoundsneuroprotective compoundstomato

Identifiers

PMID41300086
PMCPMC12651413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.